Clinical Trial Update: Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the combination of selinexor and venetoclax with chemotherapy in pediatric and young adult patients with refractory or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia of Ambiguous Lineage

Drugs mentioned

• Selinexor (selinexor)
• Venetoclax (venetoclax)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Acute Leukemia of Ambiguous Lineage in Relapse, Acute Myeloid Leukemia, in Relapse | Phase 1 | Status: ACTIVE_NOT_RECRUITING